info@targetmol.com    Tel: (857) 239-0968 / (617) 419-7131
Home > PDGFR
PDGFR
Cat.No. Product Name Information Area
T3476 JI-101 JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth fac... Cardiovascular
T6930 Pazopanib HCl (GW786034 HCl) Pazopanib HCl (GW786034 HCl) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEG... Others
T2288 Motesanib Motesanib is an orally bioavailable receptor tyrosine kinase inhibitor with potential... Cancer
T6711 Tyrphostin AG 1296 Tyrphostin AG 1296 is an inhibitor of PDGFR with IC50 of 0.3-0.5 μM, no activity to E... Cancer
T6230 Imatinib (STI571) Imatinib is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0... Cancer
T6124 Mubritinib (TAK 165)new Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2 with IC50 of 6 nM; no activi... Cancer
T6091 CP-673451 CP-673451 is a selective inhibitor of PDGFRα/β with IC50 of 10 nM/1 nM, exhibits >450... Cancer
T3072 XL019 XL019 is a potent and selective JAK2 inhibitor with IC50 of 2.2 nM, exhibiting >50-fo... Cancer
T2734 Sennoside B Extracted from Puffer fish,salamanders,frogs foot spot; Suitability:Acidic aqueous so... Cancer
T2677 Crenolanib Crenolanib (CP-868596) is a potent and selective inhibitor of PDGFRα/β with Kd of 2.1... Cancer
T2624 OSI-930 OSI-930 is a potent inhibitor of Kit, KDR and CSF-1R with IC50 of 80 nM, 9 nM and 15 ... Cancer
T2609 Masitinib Masitinib is a novel inhibitor for Kit and PDGFRα/β with IC50 of 200 nM and 540 nM/80... Cancer
T2516 Amuvatinib(MP470) Amuvatinib (MP-470) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt... Cancer
T2514 Linifanib Linifanib (ABT-869) is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR,... Cancer
T2500 Cediranib Cediranib (AZD2171) is a highly potent VEGFR(KDR) inhibitor with IC50 of <1 nM, also ... Cancer
T2479 Tyrphostin A9 Tyrphostin 9 is firstly designed as an EGFR inhibitor with IC50 of 460 μM, but is als... Cancer
T2446 KI8751 Ki8751 is a potent and selective inhibitor of VEGFR2 with IC50 of 0.9 nM, >40-fold se... Cancer
T2415 PP121 PP-121 is a multi-targeted inhibitor of PDGFR, Hck, mTOR, VEGFR2, Src and Abl with IC... Cancer
T2372 Ponatinib Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2,... Cardiovascular System
T2288L Motesanib Diphosphate (AMG-706) Motesanib Diphosphate (AMG-706) is a potent ATP-competitive inhibitor of VEGFR1/2/3 w... Cancer
T2070 CEP-32496 CEP-32496 is a highly potent inhibitor of BRAF(V600E/WT) and c-Raf with Kd of 14 nM/3... Other
T2047 AG-1478 AG-1478 (Tyrphostin AG-1478) is a selective EGFR inhibitor with IC50 of 3 nM in cell-... Cancer
T1895 SKLB610 SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kin... Cancer
T1836 AZD2932 AZD2932 is a new series of quinazoline ether inhibitor which potently inhibits VEGFR-... Other
T1792 Regorafenib Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDG... Cancer
T1785 Palbociclib Palbociclib (PD-0332991) is an orally available pyridopyrimidine-derived cyclin-depen... Cancer
T1777 BIBF 1120 Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1... Other
T1667 Tandutinib Tandutinib (MLN518, CT53518) is a potent FLT3 antagonist with IC50 of 0.22 μM, also i... Cancer
T1621 Imatinib Mesylate Imatinib mesylate is a tyrosine kinase inhibitor IC50 value of 100 nM, 100 nM, 600 nM... Cancer
T1452 Axitinib Axitinib is an oral, potent, and selective inhibitor of vascular endothelial growth f... Cancer
1